Nanoparticles and targeted drug delivery in cancer therapy

B Bahrami, M Hojjat-Farsangi, H Mohammadi… - Immunology letters, 2017 - Elsevier
Surgery, chemotherapy, radiotherapy, and hormone therapy are the main common anti-
tumor therapeutic approaches. However, the non-specific targeting of cancer cells has made …

Nanomedicine in pulmonary delivery

HM Mansour, YS Rhee, X Wu - International journal of …, 2009 - Taylor & Francis
The lung is an attractive target for drug delivery due to noninvasive administration via
inhalation aerosols, avoidance of first-pass metabolism, direct delivery to the site of action …

The role of cell‐penetrating peptides in potential anti‐cancer therapy

M Zhou, X Zou, K Cheng, S Zhong, Y Su… - Clinical and …, 2022 - Wiley Online Library
Due to the complex physiological structure, microenvironment and multiple physiological
barriers, traditional anti‐cancer drugs are severely restricted from reaching the tumour site …

Airway mucus in pulmonary diseases: Muco-adhesive and muco-penetrating particles to overcome the airway mucus barriers

R Pangeni, T Meng, S Poudel, D Sharma… - International journal of …, 2023 - Elsevier
Airway mucus is a complex viscoelastic gel that provides a defensive physical barrier and
shields the airway epithelium by trapping inhaled foreign pathogens and facilitating their …

Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers

VP Torchilin - Advanced drug delivery reviews, 2008 - Elsevier
Cell-penetrating peptides (CPPs) including TAT peptide (TATp) have been successfully
used for intracellular delivery of a broad variety of cargoes including various nanoparticulate …

[HTML][HTML] Recent advances in nanoparticle applications in respiratory disorders: a review

ME Taghavizadeh Yazdi, M Qayoomian… - Frontiers in …, 2023 - frontiersin.org
Various nanoparticles are used in the discovery of new nanomedicine to overcome the
shortages of conventional drugs. Therefore, this article presents a comprehensive and up-to …

Application of nanotechnology in the COVID-19 pandemic

D Yang - International journal of nanomedicine, 2021 - Taylor & Francis
Abstract COVID-19, caused by SARS-CoV-2 infection, has been prevalent worldwide for
almost a year. In early 2000, there was an outbreak of SARS-CoV, and in early 2010, a …

Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases

CF Anderson, ME Grimmett… - Wiley Interdisciplinary …, 2020 - Wiley Online Library
Respiratory illnesses are prevalent around the world, and inhalation‐based therapies
provide an attractive, noninvasive means of directly delivering therapeutic agents to their site …

Cell penetrating peptide‐modified pharmaceutical nanocarriers for intracellular drug and gene delivery

VP Torchilin - Peptide Science, 2008 - Wiley Online Library
Cell‐penetrating peptides (CPPs) including TAT peptide (TATp) have been successfully
used for intracellular delivery of a broad variety of cargos including various nanoparticulate …

Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases

M Mehta, N Sharma, M Vyas, N Khurana… - Chemico-biological …, 2019 - Elsevier
Macrophages are considered as the most flexible cells of the hematopoietic system that are
distributed in the tissues to act against pathogens and foreign particles. Macrophages are …